The University of Chicago Header Logo

Connection

Gini Fleming to Tubulin Modulators

This is a "connection" page, showing publications Gini Fleming has written about Tubulin Modulators.
Connection Strength

0.112
  1. Preclinical discovery of candidate genes to guide pharmacogenetics during phase I development: the example of the novel anticancer agent ABT-751. Pharmacogenet Genomics. 2013 Jul; 23(7):374-81.
    View in: PubMed
    Score: 0.112
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.